British-Swedish drugmaker AstraZeneca has been approved by the FDA for its once-a-day Xigduo XR extended-release tablet to treat adults with type 2 diabetes mellitus in the United States. AstraZeneca’s once-daily tablet is indicated as an adjunct therapy to diet and exercise to improve glycaemic control. Xigduo XR is already approved in Australia, and Xigduo is[…]
Xigduo FDA Approved for Once Daily Type 2 Diabetes Treatment
Anti-Diabetic, Blood Glucose Regulator, FDA Approved 2014, OTC and Compounding Product Tags: Australiatype 2 Diabetes Nov 03, 2014
Ivacaftor and Lumacaftor Create Positive Results for Common CF Mutation
Drug Research & Development API, NDA, Respiratory Tract Agent Tags: AustraliaCFcystic fibrosis Aug 07, 2014
Recently revealed results from a successful Phase 3 study combining Ivacaftor {Kalydeco} and Lumacaftor {VX-809} are extremely positive for patients with a common Cystic Fibrosis {CF} mutation. Patients who have the mutation of Cystic Fibrosis, which entails two copies of the F508del, have demonstrated in Phase 3 clinical trials an effective response to treatment with[…]
Can Testosterone Be Used As a Preventative Treatment For Type 2 Diabetes In Men?
Anti-Diabetic, Drug Research & Development API, Hormonal Agent, OTC and Compounding Product, Patent Expiration 2017 Tags: AustraliaCDCtype 2 Diabetes Apr 22, 2013
Is Testosterone a potential preventative treatment for type 2 diabetes? Researchers at the University of Adelaide in Australia are hopeful that their latest research will be the kick-start for trials of testosterone as a preventative for this encompassing from of diabetes. Results from early stages of this current study, which were discussed at the 10th[…]
West Nile Virus Cases Show a 35% Increase in One Week
Anti-Retroviral / Anti-HIV, Antiviral, Bulk Active Ingredient, Cardiovascular Agent, Drug Research & Development API, TEVA API Tags: Australiaribavirin Sep 13, 2012
The CDC announced on Tuesday September 13, 2012 that the West Nile virus outbreak, which recently hit the U.S., is showing no signs of relenting, with an astounding 35% increase in cases from last week. With 2,636 cases involving people, including 118 deaths, all states except Alaska and Hawaii have reported at least one case[…]
